中国医药导报
中国医药期刊欢迎您 今天是   2025年4月9日星期三
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  妇幼医学 本期目录 | 过刊浏览 | 高级检索 |
高纯度尿促性素对不同年龄卵巢储备功能减退患者体外受精的影响
赵海君1      卢静1      张一娇1▲      王玉红1      陈静1      景丽1      常月婷2      张洪峰3
1.河北省邯郸市中心医院生殖医学科,河北邯郸   056000;
2.河北省石家庄市第四医院妇二科,河北石家庄   050000;
3.河北省邯郸市中心医院科研科,河北邯郸   056000
Effect of highly purified human menopausal gonadotrophin on in vitro fertilization in patients with diminished ovarian reserve at different ages#br#
ZHAO Haijun1   LU Jing1   ZHANG Yijiao1▲   WANG Yuhong1   CHEN Jing1   JING Li1   CHANG Yueting2   ZHANG Hongfeng3
1.Department of Reproductive Medicine, Handan Central Hospital, Hebei Province, Handan   056000, China; 
2.Department of Second Gynecology, Shijiazhuang Fourth Hospital, Hebei Province, Shijiazhuang   050000, China; 
3.Department of Scientific Research, Handan Central Hospital, Hebei Province, Handan   056000, China
全文: PDF (559 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨高纯度尿促性素(HP-hMG)对卵巢储备功能减退(DOR)患者体外受精-胚胎移植的影响。 方法 选取2015年7月至2019年12月河北省邯郸市中心医院133例DOR患者,根据治疗方案将其分为重组促卵泡素组(A组,67例)和HP-hMG组(B组,66例);将两组根据年龄(<35岁或≥35岁)继续分组,比较不同年龄下两组卵巢反应和妊娠结局。 结果 <35岁患者:B组促性腺激素(Gn)用量多于A组,扳机日雌激素(E2)水平低于A组,差异有统计学意义(P < 0.05)。两组累积妊娠率、累积活产率比较,差异无统计学意义(P > 0.05)。≥35岁患者:B组Gn用量、优质胚胎率高于A组,扳机日E2水平、获卵数低于A组,差异有统计学意义(P < 0.05)。两组累积妊娠率、累积活产率比较,差异无统计学意义(P > 0.05)。 结论 HP-hMG可明显提高≥35岁DOR患者的优质胚胎率。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
赵海君1 卢静1 张一娇1▲ 王玉红1 陈静1 景丽1 常月婷2 张洪峰3
关键词 高纯度尿促性素卵巢储备功能减退超促排卵优质胚胎    
Abstract:Objective To investigate the effect of highly purified human menopausal gonadotropin (HP-hMG) on in vitro fertilization-embryo transfer in patients with diminished ovarian reserve (DOR) at different ages. Methods A total of 133 DOR patients from Handan Central Hospital of Hebei Province from July 2015 to December 2019 were selected, and they were divided into recombinant follicle stimulating hormone group (group A, 67 cases) and HP-hMG group (group B, 66 cases) according to treatment regimen; the two groups were further divided according to age (<35 years or ≥35 years), the ovarian response and pregnancy outcomes of the two groups at different ages were compared. Results Patients aged <35 years old: the amount of gonadotropin (Gn) in group B was higher than that in group A, and estrogen (E2) level on trigger day was lower than that in group A, with statistical significances (P < 0.05). There were no significant differences in cumulative pregnancy rate and cumulative live birth rate between two groups (P > 0.05). Patients aged ≥35 year old: the amount of Gn and top quality embryo rate in group B were higher than those in group A, E2 level on trigger day and egg number obtained were lower than those in group A, with statistical significances (P < 0.05). There were no significant differences in cumulative pregnancy rate and cumulative live birth rate between two groups (P > 0.05). Conclusion HP-hMG can significantly improve top quality embryo rate of DOR patients ≥35 years old.
Key wordsHighly purified human menopausal gonadotrophin    Diminished ovarian reserve    Controlled ovarian stimulation    Top quality embryo
    
基金资助:河北省健康医疗与生物医药专项(182777197);
河北省邯郸市科学技术研究与发展计划项目(19422083009-7)。
通讯作者: ▲通讯作者   
作者简介: 赵海君(1985.10-),女,硕士;研究方向:辅助生殖技术。
引用本文:   
赵海君1 卢静1 张一娇1▲ 王玉红1 陈静1 景丽1 常月婷2 张洪峰3. 高纯度尿促性素对不同年龄卵巢储备功能减退患者体外受精的影响[J]. 中国医药导报, 2021, 18(33): 111-114.
ZHAO Haijun1 LU Jing1 ZHANG Yijiao1▲ WANG Yuhong1 CHEN Jing1 JING Li1 CHANG Yueting2 ZHANG Hongfeng3. Effect of highly purified human menopausal gonadotrophin on in vitro fertilization in patients with diminished ovarian reserve at different ages#br#. 中国医药导报, 2021, 18(33): 111-114.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2021/V18/I33/111

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司